Stocks and Investing
Stocks and Investing
Thu, December 20, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, December 19, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 18, 2018
Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $67 on, Dec 18th, 2018
Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $68 to $67 on, Dec 18th, 2018.
Matthew has made no other calls on AVNS in the last 4 months.
There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kristen Stewart of "Barclays" Initiated at Hold and Held Target at $69 on, Tuesday, October 16th, 2018